Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Interest & Investment Income (2017 - 2026)

Inspire Medical Systems' Interest & Investment Income history spans 10 years, with the latest figure at $3.7 million for Q1 2026.

  • On a quarterly basis, Interest & Investment Income fell 26.15% to $3.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $16.2 million, a 27.6% decrease, with the full-year FY2025 number at $17.5 million, down 24.57% from a year prior.
  • Interest & Investment Income hit $3.7 million in Q1 2026 for Inspire Medical Systems, down from $4.0 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for INSP hit a ceiling of $5.9 million in Q1 2024 and a floor of $34000.0 in Q1 2022.
  • Historically, Interest & Investment Income has averaged $4.1 million across 5 years, with a median of $4.5 million in 2025.
  • The widest YoY moves for Interest & Investment Income: up 22360.0% in 2022, down 40.35% in 2022.
  • Tracing INSP's Interest & Investment Income over 5 years: stood at $3.4 million in 2022, then soared by 74.24% to $5.9 million in 2023, then decreased by 5.42% to $5.6 million in 2024, then dropped by 27.95% to $4.0 million in 2025, then decreased by 6.48% to $3.7 million in 2026.
  • Business Quant data shows Interest & Investment Income for INSP at $3.7 million in Q1 2026, $4.0 million in Q4 2025, and $4.0 million in Q3 2025.